Introducing Insudex®
The first and only point-of-care tests for early detection of type-1 diabetes and LADA
(Latent Autoimmune Diabetes in Adults)
Salient Features of Insudex® Test
10-15 minutes to read from a finger stick or serum sample
Quantitative autoantibody titers obtained with reader
Who Should Use Insudex®?
Children with suspected classical Type 1 diabetes and their siblings.
Children or adolescents who present with putative Type 2 diabetes, but who may, in fact, have Type 1 diabetes.
Adults suspected of having Type 1 diabetes.
Patients with established or pre (Type 2) diabetes.
Diabetes patients who may have developing or established autoimmune complications.
Pregnant women with putative gestational diabetes who may have undiagnosed Type 1 diabetes.
Autoantibodies can be present years before clinical symptoms:
a tool for early prediction of risk.
Introducing the first and only point-of-care tests for early detection of type-1 diabetes and LADA
(Latent Autoimmune Diabetes in Adults)
Three Tests for Three Autoantibodies:
Insulin Autoantibodies to insulin (IAA) can predict risk of type-1 diabetes or confirm a diagnosis of type-1 diabetes. IAA are most common in children with or at risk for type-1 diabetes.
GAD, GAD65 Autoantibodies to GAD (GADA), like IAA, are also predictive of risk for type-1 diabetes. GAD autoantibodies are present in the majority of adult patients with autoimmune diabetes.
IA-2 Autoantibodies against IA-2 (IA2-A) are the second most common autoantibody in type-1 diabetes. GAD and IA-2 autoantibodies are the most common in type-2 diabetes that also has an autoimmune component.
For children, the number of autoantibodies present is a better predictor of disease risk than the presence of any single antibody.
Who Should Be Tested
√ Children with suspected classical type-1 diabetes and their siblings.
√ Children or adolescents who present with putative type-2 diabetes, but who may, in fact, have type-1 diabetes. These patients are a distinct group that is not distinguishable without autoantibody screening, and may benefit from different interventions.
√ Adults suspected of having type-1 diabetes, since a significant proportion of type-1 diabetes patients are diagnosed as adults.
√ Patients with established or pre (type-2) diabetes in which the presence of autoantibodies in addition to insulin resistance may predict a more rapid progression to insulin deficiency.
√ Diabetes patients who may have developing or established autoimmune complications such as celiac disease or autoimmune thyroid disease.
√ Pregnant women with putative gestational diabetes who may have undiagnosed type-1 diabetes.
About the Reader
Our reader is a first-of-its-kind, quantitative, reader that incorporates real-time test data acquisition and transfer to mobile devices.
